Elsevier Drug Discovery & Development Survey
Innovation and Performance: What’s data got to do with it?
Pharmaceutical companies must uphold patient safety and manage pharmacovigilance regulatory compliance risks.
Identifying adverse events and safety signals from multiple sources quickly enough so companies can react to it continues to be a challenge, especially as the volume of available literature and data continues to increase.
How are industry leaders driving business performance amidst
big data? What are the leading practices for harnessing data to create innovative and new drugs and treatments? What are the common challenges and bottlenecks?
Help us deliver a comprehensive report by participating in a survey on current industry practices.
Participants of the survey will receive a free copy of key findings from the survey in June 2017. The survey should take approximately 15 minutes to complete.
All survey responses are anonymous so that responses are not associated with specific company names.
To receive the free report, you must complete the survey and be a professional with job responsibilities related to pharmacovigilance in a pharmaceutical company. A valid work email is required to receive the report.
By submitting this form you also agree to receive information relevant to your interests from Elsevier B.V. and its affiliates worldwide. You can opt-out at any time by following the instructions given in the email messages you receive.
Elsevier's R&D Solutions supporting 'Innovation and Performance: What’s data got to do with it?'
Drive successful early drug discovery by providing chemists the shortest path to relevant literature, patent information, valid compound properties, and experimental procedures.
Learn more about Reaxys
Contact a Reaxys expert
Reaxys Medicinal Chemistry
Achieve more efficient hit identification and lead optimization by providing chemists the shortest path to normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.
Learn more about Reaxys Medicinal Chemistry
Contact a Reaxys Medicinal Chemistry expert
Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium
Contact a PharmaPendium expert
Streamline target and biomarker identification and drug repurposing by providing biological researchers with greater insight into the mechanisms of disease and facilitating the interpretation of experimental data.
Learn more about Pathway Studio
Contact a Pathway Studio expert
Help researchers understand the entire breadth of research surrounding a disease by helping them more effectively and efficiently search authoritative, full-text scientific, technical and health content.
Learn more about ScienceDirect
Contact a ScienceDirect expert